This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Jan;13(1):1-2.

doi: 10.1080/17474124.2019.1543587. Epub 2018 Nov 13.

Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?

Grace Hatton¹, Debbie L Shawcross¹

Affiliations

PMID: 30791837
DOI: 10.1080/17474124.2019.1543587

Editorial

Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?

Grace Hatton et al. Expert Rev Gastroenterol Hepatol. 2019 Jan.

. 2019 Jan;13(1):1-2.

doi: 10.1080/17474124.2019.1543587. Epub 2018 Nov 13.

Authors

Grace Hatton¹, Debbie L Shawcross¹

Affiliation

¹ a Liver Sciences, School of Immunology and Microbial Science, Faculty of Life Sciences and Medicine , King's College London , London , UK.

PMID: 30791837
DOI: 10.1080/17474124.2019.1543587

No abstract available

Keywords: Cirrhosis; faecal microbiota transplantation; gut dysbiosis; gut microbiome; hepatic encephalopathy; immune dysfunction.

PubMed Disclaimer

Similar articles

Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
Suk KT, Kim DJ. Suk KT, et al. Expert Rev Gastroenterol Hepatol. 2019 Mar;13(3):193-204. doi: 10.1080/17474124.2019.1569513. Epub 2019 Jan 25. Expert Rev Gastroenterol Hepatol. 2019. PMID: 30791767 Review.
Gut microbiota and host metabolism in liver cirrhosis.
Usami M, Miyoshi M, Yamashita H. Usami M, et al. World J Gastroenterol. 2015 Nov 7;21(41):11597-608. doi: 10.3748/wjg.v21.i41.11597. World J Gastroenterol. 2015. PMID: 26556989 Free PMC article. Review.
Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
Babickova J, Gardlik R. Babickova J, et al. World J Gastroenterol. 2015 Oct 28;21(40):11321-30. doi: 10.3748/wjg.v21.i40.11321. World J Gastroenterol. 2015. PMID: 26525290 Free PMC article. Review.
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications.
Ponziani FR, Gerardi V, Pecere S, D'Aversa F, Lopetuso L, Zocco MA, Pompili M, Gasbarrini A. Ponziani FR, et al. World J Gastroenterol. 2015 Nov 21;21(43):12322-33. doi: 10.3748/wjg.v21.i43.12322. World J Gastroenterol. 2015. PMID: 26604640 Free PMC article. Review.
The Gut Microbiota in Celiac Disease and probiotics.
Chibbar R, Dieleman LA. Chibbar R, et al. Nutrients. 2019 Oct 5;11(10):2375. doi: 10.3390/nu11102375. Nutrients. 2019. PMID: 31590358 Free PMC article. Review.

See all similar articles

Cited by

Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multicenter Inpatient Cirrhosis Cohort.
Bajaj JS, Tandon P, O'Leary JG, Reddy KR, Garcia-Tsao G, Thuluvath P, Lai JC, Subramanian RM, Vargas HE, Wong F, Fagan A, McGeorge S, Thacker LR, Kamath PS. Bajaj JS, et al. Clin Gastroenterol Hepatol. 2023 Apr;21(4):1031-1040.e3. doi: 10.1016/j.cgh.2022.03.046. Epub 2022 Apr 15. Clin Gastroenterol Hepatol. 2023. PMID: 35436625 Free PMC article.
Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning.
Saboo K, Petrakov NV, Shamsaddini A, Fagan A, Gavis EA, Sikaroodi M, McGeorge S, Gillevet PM, Iyer RK, Bajaj JS. Saboo K, et al. J Hepatol. 2022 Mar;76(3):600-607. doi: 10.1016/j.jhep.2021.11.011. Epub 2021 Nov 15. J Hepatol. 2022. PMID: 34793867 Free PMC article.
Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver.
Gupta H, Suk KT, Kim DJ. Gupta H, et al. J Clin Med. 2021 Feb 2;10(3):541. doi: 10.3390/jcm10030541. J Clin Med. 2021. PMID: 33540624 Free PMC article. Review.
Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy.
Saboo K, Shamsaddini A, Iyer MV, Hu C, Fagan A, Gavis EA, White MB, Fuchs M, Heuman DM, Sikaroodi M, Iyer RK, Gillevet PM, Bajaj JS. Saboo K, et al. J Hepatol. 2021 Jan;74(1):80-88. doi: 10.1016/j.jhep.2020.06.046. Epub 2020 Jul 15. J Hepatol. 2021. PMID: 32679299 Free PMC article.
Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis.
Bajaj JS, Shamsaddini A, Acharya C, Fagan A, Sikaroodi M, Gavis E, McGeorge S, Khoruts A, Fuchs M, Sterling RK, Lee H, Gillevet PM. Bajaj JS, et al. Gut Microbes. 2021 Jan-Dec;13(1):1993584. doi: 10.1080/19490976.2021.1993584. Gut Microbes. 2021. PMID: 34743650 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information